Label: BLEMISH SPOT TREATMENT- salicylic acid cream
- NDC Code(s): 83657-472-01
- Packager: Skin Script, LLC
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated June 28, 2024
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredients
- Purpose
- Uses
- Questions or comments?
-
Warnings
Warnings
For external use only
When using this product · skin irritation and dryness is more likely to occur if you use
another topical acne medication at the same time. If irritation occurs, only use one
topical acne medication at a time.
Stop use and ask a doctor if rash occurs.
Keep out of reach of children. If swallowed, get medical help or contact a Poison
Control Center right away.
- Keep Out of Reach of Children
-
Directions
Directions
· Clean the skin thoroughly before applying this product · Cover the entire affected area
with a thin layer one to three times daily · Because excessive drying of the skin may
occur, start with one application daily, then gradually increase to two or three times
daily if needed or as directed by a skin care professional · If bothersome dryness or
peeling occurs, reduce application to once a day or every other day
-
Inactive Ingredients
Inactive Ingredients
Aqua (Water), Glycerin, Caprylic/Capric Triglyceride, Glycolic Acid, Coco-Caprylate/Caprate,
Cetearyl Alcohol, Cetearyl Glucoside, Glyceryl Stearate, Dicaprylyl Ether, Gluconolactone,
Xanthan Gum, Sodium Benzoate, Lithium Magnesium Sodium Silicate, Acetyl Tributyl Citrate,
Hamamelis Virginiana (Witch Hazel) Water, Fructooligosaccharides (D-beta), Alcohol,
Glucosamine HCl (D), Phenyl t-Butylnitrone (Spin Trap), Citric Acid, Sodium Hydroxide
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
BLEMISH SPOT TREATMENT
salicylic acid creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:83657-472 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 0.01 g in 1 g Inactive Ingredients Ingredient Name Strength BETA VULGARIS ROOT FRUCTOOLIGOSACCHARIDES (UNII: N2UDM48ZD6) CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S) GLYCERIN (UNII: PDC6A3C0OX) COCO-CAPRYLATE/CAPRATE (UNII: 8D9H4QU99H) CETEARYL GLUCOSIDE (UNII: 09FUA47KNA) LAPONITE (UNII: D703131383) SODIUM BENZOATE (UNII: OJ245FE5EU) WATER (UNII: 059QF0KO0R) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) DICAPRYLYL ETHER (UNII: 77JZM5516Z) SODIUM HYDROXIDE (UNII: 55X04QC32I) GLUCOSAMINE HYDROCHLORIDE (UNII: 750W5330FY) XANTHAN GUM (UNII: TTV12P4NEE) GLYCOLIC ACID (UNII: 0WT12SX38S) GLUCONOLACTONE (UNII: WQ29KQ9POT) ACETYLTRIBUTYL CITRATE (UNII: 0ZBX0N59RZ) WITCH HAZEL (UNII: 101I4J0U34) ALCOHOL (UNII: 3K9958V90M) GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) PHENYL-N-TERT-BUTYLNITRONE (UNII: 3I91332OPG) CITRIC ACID ACETATE (UNII: DSO12WL7AU) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:83657-472-01 15 g in 1 BOTTLE, DISPENSING; Type 0: Not a Combination Product 10/01/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M006 10/01/2024 Labeler - Skin Script, LLC (050951910)